Treatment Options for Stage III Colon Cancer

hero symbol

Fight Colorectal Cancer’s Medical Advisory Board Member, Axel Grothey, MD, focused this discussion on stage III colon cancer patients. Dr. Grothey, a medical oncologist at Mayo Clinic, will spend the hour discussing current treatment options and exciting new research that pertains to stage III colon cancer patients.

Watch the Webinar on YouTube

View the Slides on Slideshare

About the Presenter

Dr. Axel Grothey, MD

Axel Grothey, MD, is a consultant in the Division of Medical Oncology, Department of Oncology, at Mayo Clinic. He holds the academic rank of professor of oncology in Clinical and Translational Science at Mayo Graduate School. He is a member of Mayo Clinic’s Cancer Center.

Dr. Grothey’s clinical interests focus on gastrointestinal cancers, in particular, colorectal cancer, anti-angiogenesis, signal transduction inhibitors, and clinical trial design and statistics. As a consultant and investigator, his research has been funded by the National Cancer Institute (NCI) and the National Institutes of Health, among other organizations.

Dr. Grothey serves in journal review and editorial activities for numerous medical journals and is editor for Clinical Colorectal Cancer, Emerging Cancer Therapeutics, PracticeUpdate Oncology, and Therapeutic Advances in Medical Oncology. In educational activities, he has served as a teacher, and he is a five-time recipient of Teacher of the Year recognition at Mayo Clinic. Dr. Grothey has given numerous international, national and regional presentations, as well as invited and visited professor presentations. He has co-authored more than 500 articles, books, book chapters, editorials, abstracts, and letters.